The ultimate guide for new drug launches
When new drugs hit the market, your reps either close deals – or miss out. 3 proven strategies to cut time to market and drive sales readiness.
Executive Summary
Cut time to market and achieve unmatched ROI
Once your new drug receives the green light by the European Medicines Agency (EMA), every day counts. In today’s competitive market, delays in getting new drugs to market can cost companies significantly—up to 50% of potential market share in the first year alone.
Across Europe, countless pharmaceutical companies face the same overwhelming challenge – after months, or even years, of development and regulatory hurdles, the real race begins: getting the drug to market quickly. Stronger enablement translates to higher sales and greater recognition. But it takes time and effort.
Here’s a twist: what if AI could speed up that whole process?
Picture turning the dense product information you receive into ready-to-share, interactive training for your sales team - in minutes. And more.
In this guide, you find 3 proven strategies to accelerate training creation, boost your reps’ confidence when talking to HCPs, and shorten time to market.
Explore actionable insights that allow you to empower reps to overcome sales challenges, and secure more HCP appointments.
- Challenges reps face: uncover common challenges sales teams encounter when promoting new drugs
- 3 proven strategies for swift & impactful sales enablement: gain immediate solutions you can implement to get your reps fully prepared to engage with HCPs from day one.
- Harness AI for maximum impact: discover how AI can cut weeks off your training rollout, and give you the data to show training ROI.
No more delays - just faster onboarding, higher rep confidence, and measurable sales readiness - thanks to impactful, AI-powered sales enablement.
Download the free guide and give your team the edge they need to win.
Leading companies use Retorio to explain, predict & shape behavior.